Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
108.50
+3.22 (3.06%)
May 11, 2026, 10:27 AM EDT - Market open
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.57 billion as of May 11, 2026. Its market cap has increased by 61.82% in one year.
Market Cap
8.57B
Enterprise Value
7.03B
1-Year Change
61.82%
Ranking
Category
Stock Price
$108.50
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.57B, an increase of 976.84%. That is a compound annual growth rate of 64.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 8.32B | 6.47% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.45B |
| Arrowhead Pharmaceuticals | 10.24B |
| ABIVAX Société Anonyme | 9.83B |
| Cytokinetics | 9.57B |
| Praxis Precision Medicines | 9.20B |
| Krystal Biotech | 9.01B |
| ImmunityBio | 8.91B |
| Vaxcyte | 7.65B |